24/7 Patient Assistance: 760-405-8205

Hardeep Phull, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Hardeep Phull graduated from the Case Western Reserve University School of Medicine and completed his residency program at the Scripps Green Hospital. He is specialized in Medical Oncology and board certified in Oncology. Dr. Phull has been in practice for more than 3 years and is affiliated with the Scripps Green Hospital and the Scripps Memorial Hospital La Jolla. During his career, he has also contributed to various clinical research publications.

  • Education & Training


    Case Western Reserve University School of Medicine

    Medical School


    Scripps Clinic - Scripps Green Hospital


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Scripps Green Hospital

    Languages: English/Spanish

    (858) 554-9100

    10666 N Torrey Pines Rd

    La Jolla, California 92037

    Read More

    Scripps Memorial Hospital La Jolla

    Languages: English/Spanish

    (858) 626-4123

    9888 Genesee Ave

    La Jolla, California 92037

    Read More
  • Publications & Memberships

    Dr. Hardeep Phull has contributed to 3 publications.

    Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients.

    Navaneethan, U., Kochhar, G., Phull, H., Venkatesh, P. G., Remzi, F. H., Kiran, R. P., Shen, B.; J Crohns Colitis. 2012 May.

    See more >>

    Angiotensin II type 1 (AT-1) receptor inhibition partially prevents the urodynamic and detrusor changes associated with bladder outlet obstruction: a mouse model.

    Comiter, C., Phull, H. S.; BJU Int. 2012 Jun.

    See more >>

    Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemia.

    Lu, H.,Zhou, Q.,Deshmukh, V.,Phull, H.,Ma, J.,Tardif, V.,Naik, R. R.,Bouvard, C.,Zhang, Y.,Choi, S.,Lawson, B. R.,Zhu, S.,Kim, C. H.,Schultz, P. G.; Angew. Chem. Int. Ed. Engl.. 2014 Jul 25.

    See more >>


    American Society of Clinical Oncology

    American Society of Hematology